GENNIEFY
Market News
Latest financial news and analysis from global markets
PLTR
Palantir Earnings Top Estimates As U.S. Government Growth Booms
Palantir reported Q1 earnings and revenue that beat estimates amid strength in its U.S. government business.
VRTX
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.8% year on year to $2.99 billion. The company expects the full year’s revenue to be around $13.03 billion, close to analysts’ estimates. Its non-GAAP profit of $4.47 per share was 3.8% above analysts’ consensus estimates.
VRTX
Vertex Dips On Mixed First-Quarter Report; But There's A Silver Lining
Vertex stock dipped late Monday on a mixed first-quarter report. But Vertex Pharmaceuticals kept its 2026 outlook.
JPM
S&P 500 to Hit 8,000 This Year? Here's Why JPMorgan Thinks It's Possible
The stock market has been picking up steam in recent weeks, and that trend could continue as the year goes on.
NVDA
S&P 500 to Hit 8,000 This Year? Here's Why JPMorgan Thinks It's Possible
The stock market has been picking up steam in recent weeks, and that trend could continue as the year goes on.
CL
Chevron CEO voices concern over Strait of Hormuz ship safety
Investing.com -- Chevron Corp. Chief Executive Officer Mike Wirth expressed concern about the security of ship transit through the Strait of Hormuz as the US works to restore passage through the Persian Gulf waterway.
ETSY
How The Investment Story Around Etsy (ETSY) Is Shifting After The Depop Sale
Etsy’s updated fair value price target moves from US$61.96 to US$71.72, signaling a meaningful reset in how the stock is being framed in current models. That shift sits against a backdrop of mixed analyst commentary, with some pointing to the Depop sale and core marketplace trends as positives, while others highlight questions around growth, competition and AI. As you read on, you will see how to interpret these changing views and follow the evolving narrative around Etsy. Stay updated as the...
GS
WeRide (WRD) Valuation Check As Goldman Sachs Buy Call Meets Lenovo Alliance And ADAS Momentum
Goldman Sachs’ new coverage of WeRide (WRD) has put fresh attention on the stock, as investors weigh its expanding robotaxi fleet, growing ADAS partnerships, and the large-scale Lenovo alliance. See our latest analysis for WeRide. The recent Lenovo expansion, ADAS product wins and upcoming first quarter 2026 results have arrived against mixed trading, with a 1 day share price return of a 1.04% decline, a 7 day share price return of a 6.49% decline, and an 11.53% 1 year total shareholder...
PLTR
Palantir tops first-quarter revenue estimates on strong US government demand
Palantir Technologies beat Wall Street estimates for first-quarter revenue on Monday, driven by rising demand for its data analytics software from the U.S. government and commercial clients. Revenue from U.S. commercial customers jumped 133% to $595 million, while revenue from U.S. government customers rose 84% to $687 million in the first quarter. Palantir's U.S. government segment sells data analytics and AI software to defense and intelligence agencies, while its U.S. commercial business provides enterprise AI platforms that help corporations integrate data and automate operational decisions.
VRTX
Vertex tops profit estimates as sales of new cystic fibrosis drug surge
May 4 (Reuters) - Vertex Pharmaceuticals on Monday beat Wall Street estimates for first-quarter adjusted profit, helped by a near eight-fold surge in sales of its new cystic fibrosis treatment.
INTC
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
The Street is bullish on this biotech's prospects, but is the sentiment justified?
NVDA
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
The Street is bullish on this biotech's prospects, but is the sentiment justified?